Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Avalyn Pharma is a biopharma company developing therapies for the treatment of idiopathic pulmonary fibrosis and other respiratory diseases.
GlycoEra is a biotechnology research company that produces extracellular protein degraders for the treatment of autoimmune diseases.
Reunion Neuroscience is a clinical-stage pharmaceutical company developing therapeutic solutions for underserved mental health conditions.
HepaRegeniX is developing drugs for treating acute and chronic liver diseases.
Sparrow Quantum develope and commercializes photonic quantum chip technology.
Tribune Therapeutics specializes in building promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases.
Callio Therapeutics develops next-generation, multi-payload antibody-drug conjugates (ADCs).
Newleos Therapeutics is a biotech startup dedicated to producing safer and more effective neuroscience medicines.
Commit Biologics is a biotechnology research company developing a novel immunotherapy platform for the treatment of cancer.
Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases.
Orbis Medicines is a novel macrocyclic chemistry and computational platform for oral macrocycle drug discovery.
Nuvig Therapeutics is a biotechnology company developing therapies to induce natural mechanisms to restore immune homeostasis.
Convergent Therapeutics is a pharmaceutical company that focuses on developing radiopharmaceutical therapies for prostate cancer.
Reduced develops natural flavor enhancers from upcycled produce.
Kebotix is a high-tech materials discovery and production company that reinvent the discovery of new materials using AI.
Draupnir Bio is developing a new type of cholesterol-lowering medicine which prevents blood clots in the heart.
Myricx Bio is a biotechnology company that develops novel NMT inhibitor payloads for ADCs to treat cancer.
CIRCTEC is an innovator and operator of pyrolysis technology to recycle waste into renewable fuels and circular chemicals.
Bluejay Therapeutics is a private biopharmaceutical company focused on the development of cures for infectious diseases.
Asgard Therapeutics is a Biotechnology Company.
Octave provides mental health care that's both accessible to people and sustainable for providers.
Nalu Medical is a medical technology company that develops innovative solutions for patients with chronic neuropathic pain.
Hoba Therapeutics is developing a new therapeutic protein for the treatment of neuropathic pain.
Doctor Anywhere is a telehealth company .
Novo Holdings has invested in 216 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Novo Holdings's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Pharmaceutical. The firm invests across 30 different industry categories.
Among tracked funding rounds, Callio Therapeutics received $187.0M in a Series A round. Novo Holdings's total known invested capital is $15.2B.
Novo Holdings's average investment size is $84.4M across its portfolio of 216 companies.
Recent Novo Holdings portfolio additions include Avalyn Pharma, GlycoEra, Reunion Neuroscience, HepaRegeniX, Sparrow Quantum. These companies were founded in 2020 or later.